Intrexon

Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. The Company’s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.

Type
Public
HQ
Blacksburg, US
Founded
1998
Size (employees)
640 (est)+34%
Intrexon was founded in 1998 and is headquartered in Blacksburg, US

Key People at Intrexon

Randal J. Kirk

Randal J. Kirk

CEO and Chairman
Eli Groban

Eli Groban

Director
Gregory Frost

Gregory Frost

Senior Vice President, Health Sector
Robert F. Walsh, III

Robert F. Walsh, III

Senior Vice President, Energy Sector
Thomas D. Reed

Thomas D. Reed

Founder & Chief Science Officer, Board of Directors
Samuel Broder

Samuel Broder

Chairman, Health Sector

Intrexon Office Locations

Intrexon has office in Blacksburg
Blacksburg, US

Intrexon Metrics

Intrexon Summary

Market capitalization

$2.78 B

Closing share price

$23.6
Intrexon's current market capitalization is $2.78 B.

Intrexon Financials

Intrexon's revenue is $174 M in FY, 2015 which is 141.35% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$174 M$71.9 M$23.8 M

Revenue growth, %

141.4%202.7%

Gross profit

$150 M$63.7 M

Operating income

$-138 M$-64.7 M$-57.4 M

Operating expense total

$320 M$142 M$81.8 M

Net Income

$-88 M$-85.6 M$-40.9 M

Operating cash flow

$108 M$-22 M$39.1 M

Intrexon Market Value History

Market Position – scientific research, Manufacturing & Industrial, biotech, manufacturer, molecular systems

Intrexon Online Presence

Intrexon Company Life

You may also be interested in